Solarvest BioEnergy Inc.
SVSH.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 200.00 | 400.00 | 600.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 200.00 | 400.00 | 600.00 |
| Cost of Revenue | -- | -- | 343.40K | 343.50K | 343.60K |
| Gross Profit | -- | -- | -343.20K | -343.10K | -343.00K |
| SG&A Expenses | 384.10K | 432.30K | 534.30K | 687.10K | 839.30K |
| Depreciation & Amortization | 27.50K | 31.10K | 37.60K | 39.50K | 41.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 473.30K | 521.10K | 904.40K | 1.22M | 1.49M |
| Operating Income | -473.30K | -521.10K | -904.20K | -1.22M | -1.49M |
| Income Before Tax | -546.80K | -589.40K | -982.70K | -1.27M | -1.68M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.55 | -0.59 | -0.98 | -1.27 | -1.68 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -546.80K | -589.40K | -982.70K | -1.27M | -1.68M |
| EBIT | -473.30K | -521.10K | -904.20K | -1.22M | -1.49M |
| EBITDA | -435.60K | -479.70K | -866.60K | -1.18M | -1.45M |
| EPS Basic | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 243.02M | 243.02M | 243.05M | 240.08M | 234.71M |
| Average Diluted Shares Outstanding | 243.02M | 243.02M | 243.05M | 240.08M | 234.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
